Aceragen, Inc. (ACGN)

Last Closing Price: 1.67 (2023-06-02)

Company Description

Aceragen Inc. is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. Its portfolio includes late-stage programs based on well-established biological principles. Aceragen Inc., formerly known as Idera Pharmaceuticals Inc., is based in DURHAM, N.C.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $4.86M
Net Income (Most Recent Fiscal Year) $-23.36M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 0.52
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -610.41%
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -117.43%
Return on Assets (Trailing 12 Months) -35.77%
Current Ratio (Most Recent Fiscal Quarter) 0.83
Quick Ratio (Most Recent Fiscal Quarter) 0.83
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $3.24
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) $-5.44
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 8.42M
Free Float 8.00M
Market Capitalization $14.07M
Average Volume (Last 20 Days) 0.06M
Beta (Past 60 Months) 1.13
Percentage Held By Insiders (Latest Annual Proxy Report) 5.05%
Percentage Held By Institutions (Latest 13F Reports) 12.18%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%